Literature DB >> 16928183

Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord.

Qin Chen1, Lijun Zhou, H David Shine.   

Abstract

Previously, we reported that over-expression of neurotrophin-3 (NT-3) promoted sprouting of axons in the injured but not uninjured spinal cord, suggesting that processes associated with the injury such as Wallerian degeneration (WD) participated to induce the neuroplasticity. To determine whether NT-3-induced axonal sprouting depends upon processes associated with an acute injury, we uncoupled the injury and NT-3 over-expression in time. Rats were treated with a replicationdefective adenoviral vector carrying the NT-3 gene (Adv.NT-3) 2 weeks or 4 months after receiving a unilateral lesion of their corticospinal tract (CST). Adv.LacZ was used as a control vector. Morphometric analysis of axonal sprouting was performed to measure the number of CST axons that arise from the intact CST, traverse the midline, and grow into the gray matter of the lesioned side of the spinal cord where the NT-3 was over-expressed. The number of axons sprouting across the midline was greater in the rats treated with Adv.NT-3 than in the control groups when the Adv.NT-3 was delivered 2 weeks after injury. These axons persisted for at least 6 months after Adv.NT-3 delivery. In contrast, when Adv.NT-3 was delivered 4 months after lesion, there was no significant difference in the number of CST axons that crossed the midline compared to controls. Since the processes of WD would have resolved within 4 months after injury, these data demonstrate that products of WD are a potential source of the co-inducing signals that support neuroplasticity in the presence of NT-3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928183     DOI: 10.1089/neu.2006.23.1254

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  24 in total

Review 1.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

2.  In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair.

Authors:  Noelle Comolli; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman
Journal:  Acta Biomater       Date:  2008-10-26       Impact factor: 8.947

3.  A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord.

Authors:  Lauren Conova; Jennifer Vernengo; Ying Jin; B Timothy Himes; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman; Jennifer Vernengo; Ying Jin; B Timothy Himes; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman
Journal:  J Neurosurg Spine       Date:  2011-09-02

4.  Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury.

Authors:  Abel Torres-Espín; Juan Forero; Keith K Fenrich; Ana M Lucas-Osma; Aleksandra Krajacic; Emma Schmidt; Romana Vavrek; Pamela Raposo; David J Bennett; Phillip G Popovich; Karim Fouad
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

5.  Dependence of regenerated sensory axons on continuous neurotrophin-3 delivery.

Authors:  Shaoping Hou; LaShae Nicholson; Erna van Niekerk; Melanie Motsch; Armin Blesch
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

6.  Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury.

Authors:  Ryan P Salewski; Robert A Mitchell; Carl Shen; Michael G Fehlings
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

7.  An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury.

Authors:  Gregory W J Hawryluk; Andrea Mothe; Jian Wang; Shelly Wang; Charles Tator; Michael G Fehlings
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

8.  Implications of poly(N-isopropylacrylamide)-g-poly(ethylene glycol) with codissolved brain-derived neurotrophic factor injectable scaffold on motor function recovery rate following cervical dorsolateral funiculotomy in the rat.

Authors:  Lauren Conova Grous; Jennifer Vernengo; Ying Jin; B Timothy Himes; Jed S Shumsky; Itzhak Fischer; Anthony Lowman
Journal:  J Neurosurg Spine       Date:  2013-04-12

9.  Effects of exogenous neurotrophin-3 on myocyte apoptosis and Ca(2+)-ATP enzyme levels following nerve injury in rats.

Authors:  Yu-Zhen Dong; Lin Yang; Tan Lu; Hong-Xing Zhao; Chao Ma; Yi-Lei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Theophylline regulates inflammatory and neurotrophic factor signals in functional recovery after C2-hemisection in adult rats.

Authors:  L P Singh; T S Devi; K D Nantwi
Journal:  Exp Neurol       Date:  2012-08-19       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.